Dhruv C. Rathod

Dhruv C. Rathod

Auto-generated profile, based on publicly available information

Dhruv C. Rathod

Department: Pharmaceutical Biochemistry and Bioanalytics Institution: Pharmaceutical Institute University of Bonn, Address 1: An der Immenburg 4 Bonn Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in ChemBioChem
Verified
Journal Article
Open access
SVSonali M. Vaidya
Sonali M. Vaidya
DRDhruv C. Rathod
Dhruv C. Rathod
ARAnuradha Ramoji
Anuradha Ramoji
UNUte Neugebauer
Ute Neugebauer
Diana ImhofDiana Imhof
Diana Imhof
Heme is involved in many critical processes in pathogenic bacteria as iron acquisition by these microorganisms is achieved by either direct uptake of heme or use of heme‐binding proteins called hemophores. Exploring the underlying mechanisms on a molecular level can open new avenues in understanding the host‐pathogen interactions. Any imbalance of the heme concentration has a direct impact on the bacterial growth and survival. Thus, heme‐regulated proteins that are involved in heme homeostasis poise to be promising targets for research. Similarly, naturally occurring compounds, including cysteine‐rich peptides from either plant secondary metabolites or venom toxins from vertebrates and invertebrates, have been studied for their therapeutic potential. NCR247 is such a cysteine‐rich peptide, known to be crucial for nitrogenase activity in M. truncatula and its symbiotic relation with S. meliloti . NCR247‐derived peptides were suggested to serve as high‐affinity heme‐binding molecules with remarkable heme‐capturing properties. A comprehensive biochemical and computational analysis of NCR247‐derived peptides, however, redefines their heme‐binding capacity and consequently their potential therapeutic role.